SESSION TITLE: Critical Care - ICU Management
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Wednesday, October 26, 2016 at 01:30 PM - 02:30 PM
PURPOSE: To study the safety and efficacy of Midodrine to treat hypotension in critically ill patients. We hypothesized that patients would have higher mean arterial pressure (MAP) at 4 hours and 24 hours after the first dose of Midodrine.